SMi’s 3rd Peptides Conference to Feature a Live Learning Lab on Peptide Development and Manufacturing
Registration is now live for SMi Group's 3rd Peptides Conference which takes place in London on 6th - 7th July at the Holiday Inn Kensington Forum.
London, United Kingdom, April 04, 2016 --(PR.com)-- The global peptide therapeutics market is expected to reach a value of US$23.7B by 2020 as a result of their efficacy treating a huge array of conditions including cancer, metabolic disorders, nervous system disorders and gastrointestinal disorders among others. As such, further research has been done to develop a rich pipeline of novel peptides.
SMi’s 3rd Peptide Conference, which takes place on 6th-7th July in London, will explore the latest innovations in pre-clinical peptide development essential to the advancement of next generation peptides via case studies and presentations from MedImmune, Bachem, Bicycle Therapeutics, Sanofi-Aventis, Ipsen, Protagonist Therapeutics, and many more. A complete agenda can be downloaded on http://www.peptidesevent.com/prcom.
Just one of the highlights of this year's conference is an interactive session hosted by Vincent R. Bille, Founder and Managing Director of Marble Pharma Consult. This live learning lab entitled “Strategy for successful GMP peptide development, scale-up and manufacturing” will provide insights related to process and analytical development and management of external supply operations. It will also demonstrate a life cycle approach to peptide API manufacturing including process and regulatory dimensions.
Peptides 2016 will bring together a global network of experts including
• Lutz Jermutus, Senior Director, P&D & Product Development Team Leader, MedImmune
• Dan Teufel, Head of Chemistry, Bicycle Therapeutics
• Leila Hassani-Beniddir, Senior Scientist-Novel drug delivery technologies, Ipsen Limited
• Mathias Schoffrath, Group Leader Chromatography, Sanofi-Aventis
• Saif Shubber, Scientist, MedImmune
• Ashok Bhandari, Vice President, Chemistry, Protagonist Therapeutics
• Gary Bembridge, Director of Scientific Affairs Immunology, Abzena
A complete list of speakers and their topics can be downloaded on http://www.peptidesevent.com/prcom.
For those who are interested in attending, a £300 early bird saving is currently available online which expires on 29th April. Visit http://www.peptidesevent.com/prcom for further details.
3rd Peptides Conference
6-7 July 2016
Holiday Inn Kensington Forum, London UK
www.peptidesevent.com
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
SMi’s 3rd Peptide Conference, which takes place on 6th-7th July in London, will explore the latest innovations in pre-clinical peptide development essential to the advancement of next generation peptides via case studies and presentations from MedImmune, Bachem, Bicycle Therapeutics, Sanofi-Aventis, Ipsen, Protagonist Therapeutics, and many more. A complete agenda can be downloaded on http://www.peptidesevent.com/prcom.
Just one of the highlights of this year's conference is an interactive session hosted by Vincent R. Bille, Founder and Managing Director of Marble Pharma Consult. This live learning lab entitled “Strategy for successful GMP peptide development, scale-up and manufacturing” will provide insights related to process and analytical development and management of external supply operations. It will also demonstrate a life cycle approach to peptide API manufacturing including process and regulatory dimensions.
Peptides 2016 will bring together a global network of experts including
• Lutz Jermutus, Senior Director, P&D & Product Development Team Leader, MedImmune
• Dan Teufel, Head of Chemistry, Bicycle Therapeutics
• Leila Hassani-Beniddir, Senior Scientist-Novel drug delivery technologies, Ipsen Limited
• Mathias Schoffrath, Group Leader Chromatography, Sanofi-Aventis
• Saif Shubber, Scientist, MedImmune
• Ashok Bhandari, Vice President, Chemistry, Protagonist Therapeutics
• Gary Bembridge, Director of Scientific Affairs Immunology, Abzena
A complete list of speakers and their topics can be downloaded on http://www.peptidesevent.com/prcom.
For those who are interested in attending, a £300 early bird saving is currently available online which expires on 29th April. Visit http://www.peptidesevent.com/prcom for further details.
3rd Peptides Conference
6-7 July 2016
Holiday Inn Kensington Forum, London UK
www.peptidesevent.com
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Honey de Gracia
+44 (0) 207 827 6102
http://www.peptidesevent.com/prcom
Honey de Gracia
+44 (0) 207 827 6102
http://www.peptidesevent.com/prcom
Contact
Categories